Literature DB >> 17717217

The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.

Sebastian N Stehr1, Torsten Christ, Berit Rasche, Stefan Rasche, Erich Wettwer, Andreas Deussen, Ursula Ravens, Thea Koch, Matthias Hübler.   

Abstract

BACKGROUND: Levosimendan is a novel drug used for inotropic support in heart failure, but its efficacy in local anesthetic-induced myocardial depression is not known. Therefore, we investigated the effects of levosimendan on the negative inotropic response to ropivacaine in isolated heart preparations of guinea pigs.
METHODS: Action potentials and force of contraction were studied with conventional techniques in guinea-pig papillary muscles. Heart rate, systolic pressure, the first derivative of left ventricular pressure (+dP/dt(max)), coronary flow, and PR and QRS intervals were measured in isolated constant-pressure perfused, nonrecirculating Langendorff heart preparations. Single or cumulatively increasing concentrations of levosimendan and ropivacaine were used either alone or in combination.
RESULTS: In isolated papillary muscle, ropivacaine reduced force of contraction in a concentration-dependent manner. Exposure to 10 microM levosimendan in the presence of 10 muM ropivacaine almost completely reversed the negative inotropic response. Sensitivity to the positive inotropic effect of levosimendan was not altered by 10 muM ropivacaine (-logEC50 [M] = 7.03 without versus 6.9 with ropivacaine, respectively). Action potential parameters were influenced only at the highest concentration. In the Langendorff heart, levosimendan significantly reversed the ropivacaine-induced reduction in heart rate, systolic pressure, coronary flow, and +dP/dt(max) to baseline values.
CONCLUSION: Levosimendan is an effective inotropic drug in ropivacaine-induced myocardial depression and levosimendan myocardial sensitivity, and efficacy was not affected by the local anesthetic. Our results suggest that the calcium-sensitizing action of levosimendan is effective in local anesthetic-induced cardiac depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717217     DOI: 10.1213/01.ane.0000278146.15671.03

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  Midazolam in rabbits terminates dysrhythmias caused by intracerebroventricular ropivacaine.

Authors:  Yao-Min Zhu; Zu-Yi Yuan; Hui Wu; Dan-Dan Zhou; Gui-Xia Jing
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

2.  Levosimendan combined with epinephrine improves rescue outcomes in a rat model of lipid-based resuscitation from bupivacaine-induced cardiac arrest.

Authors:  Fubei Nan; Xixi Cai; Yingchao Ye; Xuzhong Xu; Zhengqian Li; Min Li; Limei Chen
Journal:  BMC Anesthesiol       Date:  2017-09-15       Impact factor: 2.217

3.  The Coadministration of Levosimendan and Exenatide Offers a Significant Cardioprotective Effect to Isolated Rat Hearts against Ischemia/Reperfusion Injury.

Authors:  Vasileios Leivaditis; Efstratios Koletsis; Nikolaos Tsopanoglou; Nikolaos Charokopos; Cristian D'Alessandro; Konstantinos Grapatsas; Efstratios Apostolakis; Effrosyni Choleva; Maria Plota; Andreas Emmanuil; Manfred Dahm; Dimitrios Dougenis
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-12

4.  The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity.

Authors:  Ulku Kandemir; Fikret Maltepe; Baran Ugurlu; Necati Gokmen; Asli Celik
Journal:  BMC Anesthesiol       Date:  2013-10-03       Impact factor: 2.217

5.  Levosimendan is superior to epinephrine on coronary flow for lipid-base resuscitation of bupivacaine-induced asystole in the isolated rat heart.

Authors:  Hongfei Chen; Fangfang Xia; Zhousheng Jin; Kejian Shi; Yun Xia; Le Liu; Thomas J Papadimos; Xuzhong Xu; Limei Chen
Journal:  BMC Anesthesiol       Date:  2018-11-20       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.